News & Events
- 16th Annual NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Conference
- Addressing Irreproducibility in Target Validation
September 19, 2014
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 6
Bethesda, Md. 20852
This joint meeting of the NCATS Advisory Council and Cures Acceleration Network (CAN) Review Board will feature presentations by NCATS leadership, the CAN Review Board and invited guests. Presentations will include a Director’s Report, trends in NINDS funding of basic and applied neuroscience, as well as CTSA and Tissue Chip for Drug Screening program updates. Council subcommittees also will report on 1) patient engagement; 2) partnerships with pharmaceutical and biotechnology companies, and venture capital firms; and 3) medical technologies. In addition, NCATS staff will present CAN and Council Concept Clearances of proposed initiatives for consideration and approval by Council. For more information about the Advisory Council and CAN Review Board, visit the NCATS Advisory Council page and the Cures Acceleration Network Review Board page of this site.
16th Annual NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Conference
October 21-23, 2014
7:00 a.m. to 4:50 p.m. (Tues., Wed.)
7:00 a.m. to 3:50 p.m. (Thurs.)
Sheraton Albuquerque Uptown
2600 Louisiana Blvd., NE
Albuquerque, N.M. 87107
The NIH SBIR/STTR conference helps small businesses in the life science sector learn more about the approximate $700 million of annual NIH funding that is available to forge academic partnerships and build new businesses based on recently developed biotechnology.
Attendees discover how to successfully submit an application; tips for approaching partners and investors; the types of technical assistance programs for NIH offers to awardees; and have the chance to discuss specific questions with NIH SBIR and STTR subject matter experts.
October 23, 2014
8:45 a.m. to 4:35 p.m.
Novartis Institutes for Biomedical Research
250 Massachusetts Avenue
Cambridge, Mass. 02139
This one-day conference addresses a critical and timely topic in preclinical drug discovery: “A growing chorus of concern, from scientists and [the public], contends that the complex system for ensuring the reproducibility of biomedical research is failing and is in need of restructuring.”
The conference in planned around a series of talks and panels by industry, academia and government scientists, as well as editors from leading journals to lend perspective and brainstorm practical solutions. As an open forum, it is expected to bring together key biomedical scientists and stakeholders as a community with a keen interest in this topic.View Past Events